Bridging Clinical Innovation and Community Trust
Equity-driven research strategy and community-informed engagement advancing innovation in sickle cell disease.
THE CHALLENGE
Barriers Still Limit Progress in Sickle Cell Research
Sickle cell disease disproportionately affects Black communities in the United States and globally. Despite its severity, research investment, access to innovation, and community trust remain deeply fragmented. Pharmaceutical advancement alone is not enough. Research must be paired with:
Cultural Intelligence
Addressing historical mistrust.
Community-informed Strategy
Advancing inclusive research.
Trust-centered communication
Building transparent dialogue.
Equity-driven Activation
Aligning with lived experience.
What We Do
MTS Research Solutions bridges the gap between clinical research and the communities most impacted by sickle cell disease.
We partner with pharmaceutical companies, research institutions, and industry stakeholders to strengthen community engagement and support equitable participation in research.
Our work focuses on:
Research Strategy
Community-centered Approach.
Equity-Centered Messaging
Culturally-Aligned Communication.
Clinical Trial Engagement
Lived Experience Guidance.
Patient Development Insight
Strategic Advisory Support.
We do not replace scientific rigor. We strengthen it through lived-experience intelligence.
Trusted by Leaders Advancing Sickle Cell Research
